Cross-sectional screening study for Leishmania DNA and antibodies in biologic-treated patients with psoriasis living in an area endemic for leishmaniasis

Br J Dermatol. 2019 Dec;181(6):1337-1339. doi: 10.1111/bjd.18262. Epub 2019 Sep 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Protozoan / isolation & purification
  • Biological Products / adverse effects*
  • Brazil / epidemiology
  • Cross-Sectional Studies
  • DNA, Protozoan / isolation & purification
  • Endemic Diseases / prevention & control
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Leishmania / genetics
  • Leishmania / immunology
  • Leishmania / isolation & purification*
  • Leishmaniasis / diagnosis*
  • Leishmaniasis / epidemiology
  • Leishmaniasis / immunology
  • Leishmaniasis / parasitology
  • Mass Screening / methods*
  • Mass Screening / statistics & numerical data
  • Psoriasis / drug therapy*
  • Psoriasis / immunology
  • Risk Assessment

Substances

  • Antibodies, Protozoan
  • Biological Products
  • DNA, Protozoan
  • Immunosuppressive Agents